Literature DB >> 1989977

Definition of a C-reactive protein binding determinant on histones.

T W Du Clos1, L T Zlock, L Marnell.   

Abstract

C-reactive protein (CRP) is an acute phase inflammatory protein in man which binds to phosphocholine, chromatin, histones, and the 70-kDa protein of the U1 small nuclear ribonucleoprotein particle in a calcium-dependent, phosphocholine-inhibitable manner. CRP also binds to other proteins including fibronectin. The determinants involved in CRP binding to these diverse proteins have not been identified. The binding of CRP to histones was examined as these proteins are available in large quantity at high purity and subject to protease digestion with well characterized products. Histone H1 was digested with thrombin and trypsin to produce three distinct fragments, N-terminal, central globular, and C-terminal. CRP was shown only to bind to the C-terminal fragment. Binding to histone H2A was also examined. CRP binding was not diminished by cleavage of the C-terminal fragment but was greatly decreased when the central globular region of H2A was tested. Peptides were prepared to be identical to the N- and C-terminal fragments of H2A. The N-terminal (15 amino acid) fragment of H2A blocked CRP-induced precipitation of phosphocholine-coupled bovine serum albumin and histone H2A, whereas the C-terminal fragment showed no inhibition. Thus we have defined the first reported CRP binding determinant on a protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989977

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Pentraxins and IgA share a binding hot-spot on FcαRI.

Authors:  Jinghua Lu; Kristopher D Marjon; Carolyn Mold; Lorraine Marnell; Terry W Du Clos; Peter Sun
Journal:  Protein Sci       Date:  2014-01-28       Impact factor: 6.725

2.  Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats.

Authors:  Ishwarlal Jialal; Sridevi Devaraj
Journal:  Diab Vasc Dis Res       Date:  2012-07-16       Impact factor: 3.291

3.  Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions.

Authors:  Tao Fu; Jayme Borensztajn
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific.

Authors:  M P Stein; J C Edberg; R P Kimberly; E K Mangan; D Bharadwaj; C Mold; T W Du Clos
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 5.  C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.

Authors:  M B Pepys; S E Booth; G A Tennent; P J Butler; D G Williams
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects.

Authors:  Pappanaicken R Kumaresan; Sridevi Devaraj; Wenzhe Huang; Edmond Y Lau; Ruiwu Liu; Kit S Lam; Ishwarlal Jialal
Journal:  Metab Syndr Relat Disord       Date:  2013-02-27       Impact factor: 1.894

8.  Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis.

Authors:  Waliza Ansar; Sumi Mukhopadhyay; S K Hasan Habib; Shyamasree Basu; Bibhuti Saha; Asish Kumar Sen; C N Mandal; Chitra Mandal
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

9.  C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo.

Authors:  Sridevi Devaraj; Mohan R Dasu; Uma Singh; L Vijaya Mohan Rao; Ishwarlal Jialal
Journal:  Atherosclerosis       Date:  2008-06-13       Impact factor: 5.162

10.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.